Cardioprotective Properties of Omecamtiv Mecarbil against Ischemia and Reperfusion Injury

Stroethoff, M; Behmenburg, F; Meierkord, S; Bunte, S; Mayer, F; Mathes, A; Heinen, A; Hollmann, MW; Huhn, R

Huhn, R (reprint author), Univ Hosp Duesseldorf, Dept Anesthesiol, Moorenstr 5, D-40225 Dusseldorf, Germany.

JOURNAL OF CLINICAL MEDICINE, 2019; 8 (3):

Abstract

Omecamtiv mecarbil (OM) is a first-in-class myosin activator. It was developed as a new inotropic therapy option for heart failure and is currently th......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索